The US FDA has granted 510(k) clearance for Deep Reasoning AI’s NeuroDR, an AI software tool designed for neurovas CTA...
Vanda Pharmaceuticals has reported positive results from the Phase III clinical trial, Study 3601, assessing its Nereus oral therapy to...
Arrowhead Pharmaceuticals has received marketing authorisation from the UK MHRA for Redemplo as an adjunct to diet to cut triglyceride...
Abbott has commercially launched its next-generation Oncodetect MRD assay, which identifies traces of cancer in patients with solid tumours.The post...
Enanta Pharmaceuticals has dosed the first patient in its Phase IIb/III RESOLVE trial assessing zelicapavir in high-risk adult outpatients diagnosed...
Innovent Biologics has received acceptance from China's NMPA to review its sintilimab and GC101 combination for advanced melanoma.The post China’s...
Pfizer has reported data from a Phase II trial assessing PF-07872412, its investigational 25-valent pneumococcal conjugate vaccine candidate, in infants.The...
Coreline Soft has secured 510(k) clearance from the US FDA for its aortic quantitative analysis tool, AVIEW Aorta Metrics.The post...
Pathos AI has secured $237m in a Series E round to expand its clinical oncology pipeline and scale its AI...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.